R
LIVE

Serial Number

97198644

Owner

Revir Therapeutics, Inc.

Attorney

Enshan Hong

First Use Date

May 10, 2021

Filing Date

Dec 31, 2021

Add to watchlist:

No watchlists yet
View on USPTO

R Trademark

Serial Number: 97198644 • Registration: 6963961

R is a trademark filed by Revir Therapeutics, Inc. on December 31, 2021. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Revir Therapeutics, Inc. (8 trademarks)

969 G Edgewater Blvd, Suite #185
Foster City, CA 94404

Entity Type: 03

Trademark Details

Filing Date

December 31, 2021

Registration Date

January 24, 2023

First Use Anywhere

May 10, 2021

First Use in Commerce

May 10, 2021

Published for Opposition

November 8, 2022

Goods & Services

Scientific research in the field of genetics and genetic engineering; Scientific research consulting in the field of molecular biology, biotechnology, pharmaceutics, immunology and oncology, bacteriology, medical diagnostics and therapy using molecular biological, genetic engineering and biotechnological methods, and scientific research related to screening for pharmaceutically active compounds; Medical and scientific research in the field of molecular biology, biotechnology, pharmaceutics, immunology and oncology, bacteriology, medical diagnostics and therapy using molecular biological, genetic engineering and biotechnological methods, and scientific research related to screening for pharmaceutically active compounds; Scientific research and development; Scientific research and development of diagnostic methods and test processes; Scientific research and development related to technical planning and conducting of projects in the field of the supplying of medicines; Scientific consultancy services in the field of research and development of therapies and medical preparations; Provision of scientific expertise in the nature of scientific study and research in the field of medicine; Scientific research and development for medical and veterinary purposes; Medical and scientific research in the field of treatment of proliferating diseases, cancers, infectious diseases, autoimmune diseases, and neurodegenerative disease, metabolic diseases; Providing medical and scientific research information, consultancy, and advisory services in the fields of treatment of proliferating diseases, cancers, infectious diseases, autoimmune diseases, and neurodegenerative disease; Compiling data for medical and scientific research, clinical trials, and drug admission

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 24, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 24, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 8, 2022 NPUB
PUBLISHED FOR OPPOSITION
Nov 8, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 19, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 5, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 5, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 5, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 5, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 5, 2022 CNEA
ASSIGNED TO EXAMINER
Oct 4, 2022 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 1, 2022 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Sep 1, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 1, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 1, 2022 REAP
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 5, 2022 NWOS
NEW APPLICATION ENTERED
Jan 4, 2022 NWAP